📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. (2015)

First Author: Bao X

Attributed to: Developing stem cell therapies for the treatment of inherited and acquired liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/cr.2014.165

PubMed Identifier: 25512341

Publication URI: http://europepmc.org/abstract/MED/25512341

Type: Journal Article/Review

Volume: 25

Parent Publication: Cell research

Issue: 1

ISSN: 1001-0602